One study on prostate cancer showed that UHRF1 overexpression is characterized by its affinity for the promoter of silenced genes, where it modulates histone H3K9 methylation via the histone methyltransferase EZH2 [70]. This evidence concerns the gene UHRF1 and prostate carcinoma.